News|Videos|August 8, 2023
Societal CDMO: Support From Concept to Commercialization
Author(s)Societal CDMO
Societal CDMO subject matter experts explore trends in pharmaceutical drug development and highlight capabilities of the US-based pharmaceutical CDMO company.
Advertisement
Interviews featuring:
- Christopher Ellis, Business Development Director, CTS, at Societal™ CDMO
- Madeline McCarthy, Business Development Director, Sterile Fill Finish, at Societal™ CDMO
- Scott Rizzo, Senior Vice President and Chief Operating Officer at Societal™ CDMO
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
New Targets for Clinical Trials in the European Union
2
Leveraging AI/ML to Reduce Risk in Drug Development: Part One
3
Nuclear Waste to Medicine: The UK’s Lead-212 Strategy for Cancer Care
4
Shifting from Trial-and-Error to Rational Design Drives Efficiency in Pharmaceutical Formulation
5
